90Y-DOTA-nimotuzumab: Synthesis of a Promising β⁻ radiopharmaceutical.

CONCLUSIONS: The optimized conditions for a mild and easy preparation of 90Y-DOTA-nimotuzumab joined to a promising stability under physiological conditions suggest to propose this radioimmunoconjugate as a potential diagnostic radiopharmaceutical for β- radio-guided surgery.
PMID: 33397277 [PubMed - as supplied by publisher]

Source: Current Radiopharmaceuticals - January 7, 2021 Category: Radiology Tags: Curr Radiopharm Source Type: research